{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:22:52Z","timestamp":1790788972766,"version":"4.1.0"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100001403","name":"Indian Institute of Technology Kanpur","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Human Resource Development","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recombinant adeno-associated virus (AAV)-based gene therapy has been promising, but several host-related transduction or immune challenges remain. For this mode of therapy to be widely applicable, it is crucial to develop high transduction and permeating vectors that infect the target at significantly low doses. Because glycosylation of capsid proteins is known to be rate limiting in the life cycle of many viruses, we reasoned that perturbation of glycosylation sites in AAV2 capsid will enhance gene delivery. In our first set experiments, pharmacological modulation of the glycosylation status in host cells, modestly decreased (1-fold) AAV2 packaging efficacy while it improved their gene expression (\u223c74%) in vitro. We then generated 24 mutant AAV2 vectors modified to potentially create or disrupt a glycosylation site in its capsid. Three of them demonstrated a 1.3\u20132.5-fold increase in transgene expression in multiple cell lines (HeLa, Huh7, and ARPE-19). Hepatic gene transfer of these vectors in hemophilia B mice, resulted in a 2-fold increase in human coagulation factor (F)IX levels, while its T\/B-cell immunogenic response was unaltered. Subsequently, intravitreal gene transfer of glycosylation site-modified vectors in C57BL6\/J mice demonstrated an increase in green fluorescence protein expression (\u223c2- to 4-fold) and enhanced permeation across retina. Subretinal administration of these modified vectors containing RPE65 gene further rescued the photoreceptor response in a murine model of Leber congenital amarousis. Our studies highlight the translational potential of glycosylation site-modified AAV2 vectors for hepatic and ocular gene therapy applications.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.9b00959","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:57:25Z","timestamp":1570622245000},"page":"4738-4750","source":"Crossref","is-referenced-by-count":35,"title":["Molecular Engineering of Adeno-Associated Virus Capsid\nImproves Its Therapeutic Gene Transfer in Murine Models of Hemophilia\nand Retinal Degeneration"],"prefix":"10.1021","volume":"16","author":[{"given":"Bertin","family":"Mary","sequence":"first","affiliation":[{"name":"Indian Institute of Technology Kanpur , , , ,","place":["Kanpur, Uttar Pradesh, India, 208 016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Maurya","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Kanpur , , , ,","place":["Kanpur, Uttar Pradesh, India, 208 016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Kanpur , , , ,","place":["Kanpur, Uttar Pradesh, India, 208 016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Bammidi","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Kanpur , , , ,","place":["Kanpur, Uttar Pradesh, India, 208 016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center , , , ,","place":["Omaha, Nebraska, United States, 68198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-9053","authenticated-orcid":true,"given":"Giridhara R.","family":"Jayandharan","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Kanpur , , , ,","place":["Kanpur, Uttar Pradesh, India, 208 016"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"2026090308183333500_cit1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes\nfor gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"2026090308183333500_cit2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/mp060098+","article-title":"Vaccine delivery\nmethods using viral vectors","volume":"4","author":"Br\u00e5ve","year":"2007","journal-title":"Mol. Pharm."},{"key":"2026090308183333500_cit3","doi-asserted-by":"publisher","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene\ntherapy for Leber congenital amaurosis shows advancing retinal degeneration\ndespite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl.\nAcad. Sci. U.S.A."},{"key":"2026090308183333500_cit4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful\ntransduction of liver\nin hemophilia by AAV-Factor IX and limitations imposed by the host\nimmune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"2026090308183333500_cit5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/nejmoa1414221","article-title":"Long-term effect of gene therapy\non Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl.\nJ. Med."},{"key":"2026090308183333500_cit6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term\nSafety and Efficacy Following Systemic Administration of a Self-complementary\nAAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid\nProteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther."},{"key":"2026090308183333500_cit7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers\nto successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"2026090308183333500_cit8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+)\nT-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"2026090308183333500_cit9","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation\nof adeno-associated\nvirus 2 vectors: Point mutations in tyrosines lead to high-efficiency\ntransduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"key":"2026090308183333500_cit10","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1128\/jvi.02417-05","article-title":"Characterization\nof the capsid protein glycosylation of adeno-associated virus type\n2 by high-resolution mass spectrometry","volume":"80","author":"Murray","year":"2006","journal-title":"J. Virol."},{"key":"2026090308183333500_cit11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/hgtb.2016.178","article-title":"Direct\nLiquid Chromatography\/Mass Spectrometry Analysis for Complete Characterization\nof Recombinant Adeno-Associated Virus Capsid Proteins","volume":"28","author":"Jin","year":"2017","journal-title":"Hum. Gene Ther: Methods."},{"key":"2026090308183333500_cit12","doi-asserted-by":"publisher","first-page":"9605","DOI":"10.1128\/jvi.78.18.9605-9611.2004","article-title":"Effect of the addition of oligosaccharides\non the biological activities and antigenicity of influenza A\/H3N2\nvirus hemagglutinin","volume":"78","author":"Abe","year":"2004","journal-title":"J. Virol."},{"key":"2026090308183333500_cit13","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1128\/jvi.75.15.6884-6893.2001","article-title":"Adeno-Associated\nVirus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding\nfor Hemagglutination and Efficient Transduction but Differ in Sialic\nAcid Linkage Specificity","volume":"75","author":"Kaludov","year":"2001","journal-title":"J. Virol."},{"key":"2026090308183333500_cit14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/v10110644","article-title":"Site-Specific N-Glycosylation on\nthe AAV8 Capsid Protein","volume":"10","author":"Aloor","year":"2018","journal-title":"Viruses"},{"key":"2026090308183333500_cit15","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1128\/jvi.00161-16","article-title":"Characterization\nof the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site","volume":"90","author":"Huang","year":"2016","journal-title":"J. Virol."},{"key":"2026090308183333500_cit16","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1021\/bi4008676","article-title":"Characterization\nof Interactions between Heparin\/Glycosaminoglycan and Adeno-Associated\nVirus","volume":"52","author":"Zhang","year":"2013","journal-title":"Biochemistry"},{"key":"2026090308183333500_cit17","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1074\/jbc.m110.210922","article-title":"Terminal N-linked\ngalactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026090308183333500_cit18","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15013","article-title":"Post-translational\nmodifications in capsid proteins of recombinant Adeno-associated virus\n(AAV) 1-rh10 serotypes","author":"Mary","year":"2019","journal-title":"FEBS J."},{"key":"2026090308183333500_cit19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/hgtb.2012.194","article-title":"Bioengineering of AAV2 capsid at specific serine, threonine,\nor lysine residues improves its transduction efficiency in vitro and\nin vivo","volume":"24","author":"Gabriel","year":"2013","journal-title":"Hum. Gene Ther: Methods."},{"key":"2026090308183333500_cit20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection\nand quantification of adeno-associated virus serotype 2-derived inverted\nterminal repeat sequences","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum. Gene Ther: Methods."},{"key":"2026090308183333500_cit21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2174\/1389201015666140327141710","article-title":"Developing\nimmunologically inert\nadeno-associated virus (AAV) vectors for gene therapy: possibilities\nand limitations","volume":"14","author":"Selot","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2026090308183333500_cit22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1128\/jvi.74.4.1761-1766.2000","article-title":"Epitope\nmapping of human anti-adeno-associated\nvirus type 2 neutralizing antibodies: implications for gene therapy\nand virus structure","volume":"74","author":"Moskalenko","year":"2000","journal-title":"J. Virol."},{"key":"2026090308183333500_cit23","doi-asserted-by":"publisher","first-page":"e75142","DOI":"10.1371\/journal.pone.0075142","article-title":"Characterization of naturally-occurring humoral immunity\nto AAV in sheep","volume":"8","author":"Tellez","year":"2013","journal-title":"PLoS One"},{"key":"2026090308183333500_cit24","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1099\/vir.0.014175-0","article-title":"Adeno-associated\nvirus serotype 2 induces cell-mediated immune responses directed against\nmultiple epitopes of the capsid protein VP1","volume":"90","author":"Madsen","year":"2009","journal-title":"J. Gen. Virol."},{"key":"2026090308183333500_cit25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/hgtb.2015.037","article-title":"Determination of Anti-Adeno-Associated\nVirus Vector Neutralizing Antibody Titer with an In Vitro Reporter\nSystem","volume":"26","author":"Meliani","year":"2015","journal-title":"Hum. Gene Ther: Methods."},{"key":"2026090308183333500_cit26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T)\nmethod","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"2026090308183333500_cit27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel Properties\nof Tyrosine-mutant AAV2 Vectors in the Mouse Retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol. Ther."},{"key":"2026090308183333500_cit28","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1128\/jvi.78.10.5414-5422.2004","article-title":"Analysis of N-Linked\nGlycosylation of Hantaan Virus\nGlycoproteins and the Role of Oligosaccharide Side Chains in Protein\nFolding and Intracellular Trafficking","volume":"78","author":"Shi","year":"2004","journal-title":"J. Virol."},{"key":"2026090308183333500_cit29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1097\/01.lab.0000038503.34655.98","article-title":"Differential\nExpression of \u03b2-Galactoside \u03b12,6 Sialyltransferase and\nSialoglycans in Normal and Cirrhotic Liver and Hepatocellular Carcinoma","volume":"82","author":"Cao","year":"2002","journal-title":"Lab. Invest."},{"key":"2026090308183333500_cit30","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1128\/jvi.76.5.2043-2053.2002","article-title":"Ubiquitination\nof both Adeno-Associated Virus Type\n2 and 5 Capsid Proteins Affects the Transduction Efficiency of Recombinant\nVectors","volume":"76","author":"Yan","year":"2002","journal-title":"J. Virol."},{"key":"2026090308183333500_cit31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","article-title":"Virus glycosylation:\nrole in virulence and immune interactions","volume":"15","author":"Vigerust","year":"2007","journal-title":"Trends\nMicrobiol."},{"key":"2026090308183333500_cit32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1432-1033.1989.tb15008.x","article-title":"O-linked\nGlcNAc in serotype-2 adenovirus\nfibre","volume":"184","author":"Caillet-Boudin","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"2026090308183333500_cit33","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1128\/JVI.72.5.3887-3892.1998","article-title":"Carbohydrates facilitate\ncorrect disulfide bond formation\nand folding of rotavirus VP7","volume":"72","author":"Mirazimi","year":"1998","journal-title":"J. Virol."},{"key":"2026090308183333500_cit34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/viro.1996.8412","article-title":"Variable transduction\nefficiency of murine leukemia\nretroviral vector on mammalian cells: role of cellular glycosylation","volume":"229","author":"Tavoloni","year":"1997","journal-title":"Virology"},{"key":"2026090308183333500_cit35","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1128\/mbio.00862-13","article-title":"Comprehensive Functional\nAnalysis of N-Linked Glycans on Ebola Virus\nGP1","volume":"5","author":"Lennemann","year":"2014","journal-title":"mBio"},{"key":"2026090308183333500_cit36","doi-asserted-by":"publisher","first-page":"8.14.1","DOI":"10.1002\/0471142735.im0814s09","article-title":"Inhibition\nof N-linked glycosylation","volume":"9","author":"Powell","year":"1994","journal-title":"Curr. Protoc. Immunol."},{"key":"2026090308183333500_cit37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/0042-6822(91)90636-p","article-title":"Inhibition of DNA replication of\nadenovirus type 5\nand simian virus 40 by tunicamycin","volume":"182","author":"Huang","year":"1991","journal-title":"Virology"},{"key":"2026090308183333500_cit38","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1073\/pnas.89.7.2689","article-title":"Retinoic acid mimics\ntransforming growth factor beta\nin the regulation of human immunodeficiency virus expression in monocytic\ncells","volume":"89","author":"Poli","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090308183333500_cit39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0166-3542(96)01009-1","article-title":"Inhibition\nof herpes simplex virus replication by retinoic acid","volume":"33","author":"Isaacs","year":"1997","journal-title":"Antiviral Res."},{"key":"2026090308183333500_cit40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1128\/jvi.01939-08","article-title":"Identification of Cellular\nProteins That Interact with the Adeno-Associated Virus Rep Protein","volume":"83","author":"Nash","year":"2009","journal-title":"J. Virol."},{"key":"2026090308183333500_cit41","doi-asserted-by":"publisher","first-page":"e16580","DOI":"10.1371\/journal.pone.0016388","article-title":"Exploring the Evolutionary Relationship\nof Insulin Receptor Substrate Family Using Computational Biology","volume":"6","author":"Chakraborty","year":"2011","journal-title":"PLoS One"},{"key":"2026090308183333500_cit42","doi-asserted-by":"publisher","first-page":"e00391","DOI":"10.1128\/jvi.00391-17","article-title":"Adeno-associated\nvirus (AAV) serotypes have distinctive\ninteractions with domains of the cellular AAV receptor","volume":"91","author":"Pillay","year":"2017","journal-title":"J. Virol."},{"key":"2026090308183333500_cit43","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated\nheparan sulfate proteoglycan is\na receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"key":"2026090308183333500_cit44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ymthe.2005.09.009","article-title":"Identification of mouse AAV capsid-specific\nCD8+ T cell epitopes","volume":"12","author":"Sabatino","year":"2005","journal-title":"Mol. Ther."},{"key":"2026090308183333500_cit45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jgm.1327","article-title":"Subretinal delivery of adeno-associated\nvirus serotype 2 results in minimal immune responses that allow repeat\nvector administration in immunocompetent mice","volume":"11","author":"Barker","year":"2009","journal-title":"J. Gene Med."},{"key":"2026090308183333500_cit46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of\nblindness\nin animal models of leber congenital amaurosis using optimized AAV2-mediated\ngene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"2026090308183333500_cit47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1479-0556-2-3","article-title":"Recombinant adeno-associated\nvirus type 2-mediated gene delivery into the Rpe65(-\/-) knockout mouse\neye results in limited rescue","volume":"2","author":"Lai","year":"2004","journal-title":"Genet. Vaccines\nTher."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.9b00959","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/11\/4738\/67235914\/acs.molpharmaceut.9b00959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/16\/11\/4738\/67235914\/acs.molpharmaceut.9b00959.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:18:41Z","timestamp":1788437921000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/16\/11\/4738\/507331\/Molecular-Engineering-of-Adeno-Associated-Virus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,9]]},"published-print":{"date-parts":[[2019,11,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00959","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]}}}